A Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19
Public ClinicalTrials.gov record NCT04750278. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS)
Study identification
- NCT ID
- NCT04750278
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Foresee Pharmaceuticals Co., Ltd.
- Industry
- Enrollment
- 90 participants
Conditions and interventions
Interventions
- FP-025 100 mg Drug
- FP-025 300 mg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 5, 2021
- Primary completion
- Apr 17, 2022
- Completion
- Apr 17, 2022
- Last update posted
- Jan 4, 2024
2021 – 2022
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Velocity Chula Vista | Chula Vista | California | 91911 | — |
| Velocity San Diego | La Mesa | California | 91942 | — |
| Shady Grove Medical Center | Rockville | Maryland | 20850 | — |
| University of Nevada, Las Vegas (UNLV) School of Medicine | Las Vegas | Nevada | 89102 | — |
| Trinity Health Center | Minto | North Dakota | 58701 | — |
| Legacy Health | Portland | Oregon | 97210 | — |
| Houston Methodist | Houston | Texas | 77030 | — |
| United Medical Memorial Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04750278, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 4, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04750278 live on ClinicalTrials.gov.